AD Roth

3.5k citations
5 papers · 2.7k · 1 hit paper · h-index 4

Impact in

  • Hepatology top 1%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Surgical Treatments

Papers in

AD Roth

5 papers receiving 2.6k citations

AD Roth's Hit Papers

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial 2000 · 2.5k citations
2.5k0+8+17Years since publication50010001.5k2.0k2.5k

Peers

AD Roth
Comparison fields: 5 of 101
  • Hepatology 535
  • Oncology 1.7k
  • Pulmonary and Respiratory Medicine 399
  • Pathology and Forensic Medicine 218
  • Cancer Research 120
Replace Gwo Fuang Ho with:
Gwo Fuang Ho Malaysia
Hyeong Su Kim South Korea
Liyue Tong United States
Camilla Qvortrup Denmark
Rachel Goodwin Canada
Claire Jones Canada
Ana Ruiz‐Casado Spain
Mark Powell United States
Bingfeng Han China
Ishwaria M. Subbiah United States
AD Roth relative to Gwo Fuang Ho Malaysia Gwo Fuang Ho's profile →
Citations per field
00.5×3.1×
Gwo Fuang Ho · 1×
Citations per year

Countries citing papers authored by AD Roth

Since Specialization
Citations

This map shows the geographic impact of AD Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Roth more than expected).

Fields of papers citing papers by AD Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AD Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Roth. The network helps show where AD Roth may publish in the future.

Co-authors

The 16 scholars most cited alongside AD Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with AD Roth Line = papers co-authored together AD Roth links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
Hit paper breakdown →
20002531
2
The competences required to deliver effective cognitive and behavioural therapy for people with depression and with anxiety disorders
2007110
3 20115
4
Selecting for clinical training
19954
5
Getting on clinical training courses
19983

About AD Roth

AD Roth is a scholar working on Clinical Psychology, Pulmonary and Respiratory Medicine, Oncology, Experimental and Cognitive Psychology and Infectious Diseases, having authored 5 papers that have together received 2.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (1 paper), Psychological Treatments and Disorders (1 paper), Child and Adolescent Psychosocial and Emotional Development (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Psychology Research and Bibliometrics (1 paper). The work is most often cited by research in Hepatology (535 citations), Oncology (1.7k citations), Pulmonary and Respiratory Medicine (399 citations), Pathology and Forensic Medicine (218 citations) and Cancer Research (120 citations). AD Roth has collaborated with scholars based in Switzerland, Spain and Czechia. Frequent co-authors include May Alakl, G. Gruia, Matilde Navarro, Timothy Iveson, Petr Karásek, J-Y Douillard, J Carmichael, David Cunningham, Lucile Awad and P Jandı́k. Their work appears in journals such as Swiss Medical Weekly, The Lancet and UCL Discovery (University College London).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact